CLEVELAND, Ohio — The Cleveland Clinic is in the vanguard of a new era of research into psychedelic medicine. The Clinic is the only Ohio site participating in a national study looking at whether LSD, ...

Two later-stage trials investigating LSD for treating anxiety are due to conclude in 2026, which could lead to the drug being ...

In large doses, lysergic acid diethylamide (LSD) can repair damaged neurons in the brain, and reveal new ways of seeing the world. In small doses, microdosers chase the effects of the drug on ...

People have been taking LSD for decades, but experts still don’t know all that much about it, especially when it comes to how it affects your brain. Still, LSD doesn’t appear to kill brain cells. At ...

A Phase II clinical trial investigating the efficacy of the psychedelic compound lysergic acid diethylamide (LSD) in combination with psychotherapy for the treatment of anxiety has reported positive ...

LSD usage is on the rise among U.S. adults – especially young adults with depression. And the trend mirrors growing research into the psychedelic drug's ability to treat mental health disorders like ...

An incredible, first-of-its-kind trial testing the pain-killing properties of LSD microdoses has delivered the compelling suggestion that tiny, non-psychedelic doses of this infamous drug could serve ...

Psychedelic pharmaceutical company MindMed has announced the development of a novel compound designed to stop the effects of an LSD experience. The compound is claimed to function as an “off-switch” ...

On October 6th, 1966, nearly a thousand participants and three bands – including the Grateful Dead – gathered in the Panhandle of San Francisco’s Golden Gate Park to observe the criminalization of LSD ...

Lysergic acid dyethylamide, which you probably know as LSD, has been put to various uses since its discovery in the 1930s: scientists have tried to treat mental illness; the CIA attempted to control ...

Barbara Sahakian consults for Cambridge Cognition, Peak, Mundipharma. She has received funding from the Medical Research Council, Wellcome Trust, NIHR Cambridge Brain Injury HTC, the Wallitt ...